2025 Meeting: CLE accredited by the State Bar of Pennsylvania
Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit!
If you are interested in the 2026 event, please get in touch at info@hansonwade.com
Empowering Biopharma’s Legal Leaders to Navigate Market Uncertainty, Maximize
Cost Efficiency & Drive Business Success
As the regulatory landscape continues to evolve, 2025 is a pivotal year for legal leaders in biopharma. The 6th In-House Impact: Biopharma Summit was your exclusive opportunity to unite with top legal minds from Takeda, Kura Oncology, Neurocrine Biosciences, and more to tackle today’s most pressing challenges—tariffs, financing, M&A strategy, and beyond.
Tailored for General Counsels and Chief Legal Officers at drug development companies, this intimate, peer-led summit empowered attendees to elevate legal as a business-critical function. Attendees learned how in-house teams are adapting to economic volatility, harnessing new legal tech, and navigating cross-functional leadership demands, all while building a valuable network of peers.
This was not just another conference. It’s a strategic inflection point. Free to attend for biopharma’s in-house counsel, this event helped attendees transition from a traditional lawyer to a corporate leader, ready to drive business success.
Meet Your 2025 Expert Speaker Faculty




